MN

Masineni Narayanappa Apoorva

Active Director Director DIN 10121501
DIN 10121501 First appointment Apr 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2023
Shareholding value •••• Premium profile

About Masineni Narayanappa Apoorva

Data last updated:

Masineni Narayanappa Apoorva is a Director at Mando Healthcare Private Limited (since 2023). Mando Healthcare Private Limited reported revenue of ₹14.91 Cr (FY 2025).

DIN 10121501
Primary Designation Director
First Appointment 18 Apr 2023
Oldest Company Age 3 yrs
Largest company Mando Healthcare Private Limited · ₹14.91 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mando Healthcare Private Limited U86100KA2023PTC172464
Director18 Apr 20232023₹14.91 Cr (FY 2025)Active

Board colleagues of Masineni Narayanappa Apoorva

Directorship timeline

Open interactive timeline →
Mando Healthcare Private Limited
Premium access

Shareholding and investment profile for Masineni Narayanappa Apoorva

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Masineni Narayanappa Apoorva

Masineni Narayanappa Apoorva currently holds 1 directorship: Mando Healthcare Private Limited (Director, since 18 Apr 2023, revenue ₹14.91 Cr (FY 2025)).

Masineni Narayanappa Apoorva was first appointed on 18 Apr 2023 as Director at Mando Healthcare Private Limited.

The current boards of Masineni Narayanappa Apoorva's companies include Seemalamudi Udayashankar Prajoth (Mando Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available